COMMUNIQUÉS West-GlobeNewswire

-
MedBright AI Reaches US$100M in Total Clinic Revenue Under Contract with MedMatrix, the AI-Powered Data Analytics Platform
18/01/2024 -
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
18/01/2024 -
CENTOGENE Announces Preliminary Full Year 2023 Revenue
18/01/2024 -
Oxford BioTherapeutics Announces First Patient Dosed with OBT076 in Phase 1b Trial in Adenoid Cystic Carcinomas of the Head and Neck
18/01/2024 -
Orphalan announces China NMPA’s approval of its trientine tetrahydrochloride product for the treatment of Wilson disease
18/01/2024 -
Iktos announces the appointment of Avirup Bose as Chief Business Officer
18/01/2024 -
ONWARD® Announces Start of HemON NL Clinical Study
18/01/2024 -
argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis
18/01/2024 -
NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatric ADHD
18/01/2024 -
Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
18/01/2024 -
Immatics Announces Pricing of $175 Million Public Offering
18/01/2024 -
Lowell Farms Inc. Announces Termination of the Zabala Road Lease
18/01/2024 -
MedBright AI Investments Inc. Responds to OTC Markets Request on Recent Promotional Activity
18/01/2024 -
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
17/01/2024 -
StateHouse Announces Update to Board of Directors
17/01/2024 -
Sanofi: Information concerning the total number of voting rights and shares - December 2023
17/01/2024 -
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Decembre 2023
17/01/2024 -
NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
17/01/2024 -
Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
17/01/2024
Pages